Singular Genomics Systems Inc (OMIC)
22.31
+8.85
(+65.75%)
USD |
NASDAQ |
Nov 04, 16:00
22.22
-0.09
(-0.40%)
After-Hours: 20:00
Singular Genomics Systems Profit Margin (Quarterly): -2.88K% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -2.88K% |
| March 31, 2024 | -5.66K% |
| December 31, 2023 | -2.15K% |
| September 30, 2023 | -4.84K% |
| Date | Value |
|---|---|
| June 30, 2023 | -5.06K% |
| March 31, 2023 | -2.74K% |
| December 31, 2022 | -2.76K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-5.66K%
Minimum
Mar 2024
-2.15K%
Maximum
Dec 2023
-3.73K%
Average
-2.88K%
Median
Jun 2024
Profit Margin (Quarterly) Benchmarks
| Bruker Corp | 0.95% |
| Azenta Inc | -3.81% |
| Harvard Bioscience Inc | -12.67% |
| Bionano Genomics Inc | -208.8% |
| Akoya Biosciences Inc | -56.76% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -51.57% |
| Return on Assets | -35.53% |
| Return on Invested Capital | -49.19% |
| Gross Profit Margin (Quarterly) | -24.15% |
| Operating Margin (Quarterly) | -3.09K% |
| Return on Net Operating Assets | -95.68% |